Search Results 1051-1060 of 18309 for Hepatitis b

  1. Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    ... hepatitis B (HBV), or hepatitis C virus (HCV). Those who are seropositive because of hepatitis B vaccine are eligible. Patients who are positive for HBV ...

  2. Study of MK-8242 Alone and in Combination with Cytarabine in Participants with Acute Myelogenous Leukemia (P07649) - Mayo Clinic

    Arm B is for participants with recurrent AML ... B. Participation eligibility. Participant ... Clinically significant hepatitis at Screening, or hepatitis ...

  3. Autoimmune Diseases Clinical Trials - Mayo Clinic Research

    ... hepatitis (AIH), overlap AIH with Primary Biliary Cirrhosis (AIH-PBC) ... B-cell hematologic malignancies including large B-cell, mantle cell and ...

  4. A Study of the Effectiveness and Safety of Vedolizumab Compared to Adalimumab for Participants with Ulcerative Colitis - Mayo Clinic

    Has chronic hepatitis B virus (HBV) infection* or chronic hepatitis C virus (HCV) infection (* HBV immune participants, ie, being hepatitis B surface ...

  5. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

    ... Hepatitis C, Primary sclerosing cholangitis, Hepatit...is B, Cholangiocarcinoma, Hemochromatosis, Autoimmune hepatitis, Hepatocellular carcinoma, Primary ...

  6. Publications - Emrys Fonseca, M.B., B.Ch., B.A.O., M.S. - Mayo Clinic

    JJ Matthews, FD Fonseca, CV Varnado. Help-seeking behaviors of African Americans after a loss Journal of Multicultural Counseling and Development. 2021; 60-71.

  7. A Study of Healthy Donor Volunteers to Provide Blood components Via Leukapheresis for In vitro Dendritic Cell Investigations - Mayo Clinic

    No history Hepatitis B or C seropositivity. No history Infectious or Idiopathic hepatitis or unexplained jaundice. Female subjects should not be pregnant ...

  8. A Study to Evaluate the Safety, Tolerance and Anti-tumor Activity of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    Active hepatitis A, B, and C as defined below: active hepatitis A (defined as positive IgM), active hepatitis B (defined as either positive hepatitis B ...

  9. A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies - Mayo Clinic

    A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies. Print details. Share; Facebook · Twitter. Overview; Participation ...

  10. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

    * Negative serologic or polymerase chain reaction (PCR) test results for acute or chronic hepatitis B virus (HBV) infection Note: Participants whose HBV ...